Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions |
umls-concept:C0009491,
umls-concept:C0027651,
umls-concept:C0030415,
umls-concept:C0072108,
umls-concept:C0085136,
umls-concept:C0205155,
umls-concept:C0441800,
umls-concept:C0449574,
umls-concept:C0868928,
umls-concept:C1518453,
umls-concept:C1522472,
umls-concept:C1551341,
umls-concept:C1552858,
umls-concept:C1552923,
umls-concept:C1552924,
umls-concept:C1579762,
umls-concept:C1705191,
umls-concept:C1707520
|
| pubmed:issue |
9
|
| pubmed:dateCreated |
1993-9-16
|
| pubmed:abstractText |
We investigated the expression of proliferating cell nuclear antigen (PCNA) and the number of nucleolar organizer regions (NORs) in 82 cases of CNS tumors. PCNA is a nuclear protein maximally elevated in the S phase of the cell cycle and recognized immunohistochemically in paraffin sections by the monoclonal antibody PC-10. On the other hand, NORs are loops of DNA that carry the rRNA genes and can be demonstrated in paraffin sections using an argyrophilic method (AgNORs). The present study shows a significant correlation of PCNA index and of AgNOR number with the histological grade (PCNA: I versus II, p < 0.01; II versus III, p < 0.01; and III versus IV, p < 0.05; AgNORs: I versus II, p < 0.001; II versus III, p < 0.05; and III versus IV, p < 0.001). Higher values of PCNA index (0.01 < p < 0.05) were found in recurrent tumors. Metastatic carcinomas were characterized by high PCNA indices and AgNOR numbers, similar to grade IV tumors, whereas in CNS lymphomas the malignancy grade was reflected in PCNA indices and AgNOR numbers. A wide range of PCNA and AgNOR values has been observed within each histological type and grade, probably reflecting variations in the biological behavior, but little overlap in PCNA values was present between grades II and III. The latter finding might be of importance in distinguishing between low- and high-grade CNS tumors. The linear regression coefficient between PCNA index and AgNOR number was excellent (0.91). We suggest that PCNA and AgNORs may be successfully applied in routine material to assess the growth potential of CNS tumors. Their prognostic value, however, must be validated with clinical studies.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
0147-5185
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
17
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
912-9
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:8102513-Antigens, Neoplasm,
pubmed-meshheading:8102513-Central Nervous System Neoplasms,
pubmed-meshheading:8102513-Humans,
pubmed-meshheading:8102513-Nuclear Proteins,
pubmed-meshheading:8102513-Nucleolus Organizer Region,
pubmed-meshheading:8102513-Prognosis,
pubmed-meshheading:8102513-Proliferating Cell Nuclear Antigen
|
| pubmed:year |
1993
|
| pubmed:articleTitle |
Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections.
|
| pubmed:affiliation |
Department of Pathology, Asklepeion Hospital, Voula Attikis, Greece.
|
| pubmed:publicationType |
Journal Article
|